Fucoziff 300 Capsule contains Fluconazole 300 mg, a broad-spectrum antifungal agent that works by inhibiting ergosterol synthesis in fungal cell membranes, leading to cell death and effective control of fungal infections.
Clinically, Fucoziff 300 Capsule is indicated for systemic fungal infections such as candidemia, cryptococcal meningitis, and deep mycoses, as well as superficial infections like oropharyngeal and esophageal candidiasis. Its high-dose formulation is ideal for patients requiring rapid and potent antifungal therapy under medical supervision.
The capsule is formulated to ensure consistent bioavailability, precise dosing, and reliable therapeutic outcomes, making it suitable for hospitals, dermatology and infectious disease clinics, and specialty pharmacies that demand high-quality antifungal agents.
Fucoziff 300 Capsule also supports prevention of recurrence in immunocompromised patients, enhances treatment adherence due to convenient oral dosing, and provides a safe, effective, and evidence-based antifungal option for managing both systemic and superficial fungal infections.